PF-3758309
货号：
19186-5mg 基本售价：
686.0 元 规格：
5 mg
产品信息
概述| 货号 | 19186-5mg |
| 描述 | p21-Activated kinases (PAKs) are STE20 serine/threonine kinases that are vital to normal cell function. Binding of various upstream partners to PAKs results in release of an autoinhibitory domain that blocks activity of the kinase domain.1 PAKs are upregulated in several human cancers and are potential therapeutic targets for cancer intervention.1 PF-3758309 is an ATP-competitive inhibitor of PAK4, preventing the phosphorylation of the PAK4 substrate GEF-H1 (IC50 = 1.3 nM) and blocking anchorage-independent growth of a panel of tumor cell lines (IC50 = 4.7 nM).2 It also inhibits the ability of kinase domains from other PAKs to phosphorylate peptide substrates (Kis = 18.1, 17.1, 13.7, 190, and 99 nM for PAKs 5, 6, 1, 2, and 3, respectively).2 PF-3758309 blocks the growth of multiple human tumor xenografts.2 |
| 别名 | PF-309; |
性能| 供应商 | Cayman |
| 应用文献 |
1.Kumar, R.,Gururaj, A.E., and Barnes, C.J. p21-activated kinases in cancer. Nat.Rev.Cancer. 6(6), 459-471 (2006).
2.Murray, B.W.,Guo, C.,Piraino, J., et al. Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proceedings of the National Academy of Sciences of the United States of America 107(20), 9446-9451 (2010).
|
| 运输条件 | Room temperature in continental US; may vary elsewhere |
| 存放说明 | -20 |
| 纯度 | ≥98% |
| 计算分子量 | 490.6 |
| 分子式 | C25H30N8OS |
| CAS号 | 898044-15-0 |
| 稳定性 | ≥ 2 years |
声明| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |
